Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionTocqueville Asset Management L.p.
Latest Disclosed Ownership21,230 shares
Latest Disclosed Value $ 7,469,776
Tocqueville Asset Management L.p. reports 3.15% decrease in ownership of AMGN / Amgen Inc.

On May 12, 2026 - Tocqueville Asset Management L.p. filed a 13F-HR form disclosing ownership of 21,230 shares of Amgen Inc. (US:AMGN) valued at $7,469,776 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 21,920 shares of Amgen Inc.. This represents a change in shares of -3.15% during the quarter. The current value of the position is $7,421,583 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AMGEN COM 031162100 21,230 -690 -3.15 7,470 4.11 0.1108
2026-02-12 2025-12-31 13F AMGEN COM 031162100 21,920 550 2.57 7,175 18.97 0.1047
2025-11-13 2025-09-30 13F AMGEN COM 031162100 21,370 -704 -3.19 6,031 -2.16 0.0877
2025-08-12 2025-06-30 13F AMGEN COM 031162100 22,074 1,274 6.12 6,163 -4.89 0.0938
2025-05-13 2025-03-31 13F AMGEN COM 031162100 20,800 658 3.27 6,480 23.45 0.1058
2025-02-10 2024-12-31 13F AMGEN COM 031162100 20,142 -85 -0.42 5,250 -19.46 0.0823
2024-11-08 2024-09-30 13F AMGEN COM 031162100 20,227 -1,200 -5.60 6,517 -2.64 0.1024
2024-08-12 2024-06-30 13F AMGEN COM 031162100 21,427 -317 -1.46 6,695 8.28 0.1105
2024-05-09 2024-03-31 13F AMGEN COM 031162100 21,744 -58 -0.27 6,182 -1.54 0.1010
2024-02-12 2023-12-31 13F AMGEN COM 031162100 21,802 -1,049 -4.59 6,279 2.25 0.1138
2023-11-09 2023-09-30 13F AMGEN COM 031162100 22,851 -505 -2.16 6,141 18.44 0.1166
2023-08-11 2023-06-30 13F AMGEN COM 031162100 23,356 -271 -1.15 5,185 -9.21 0.0929
2023-05-10 2023-03-31 13F AMGEN COM 031162100 23,627 -139 -0.58 5,712 -8.49 0.1079
2023-02-09 2022-12-31 13F AMGEN COM 031162100 23,766 -396 -1.64 6,242 14.60 0.1186
2022-11-10 2022-09-30 13F AMGEN COM 031162100 24,162 -4,000 -14.20 5,446 -20.52 0.1110
2022-08-12 2022-06-30 13F AMGEN COM 031162100 28,162 -793 -2.74 6,852 -2.14 0.1253
2022-05-16 2022-03-31 13F Amgen COM 031162100 28,955 547 1.93 7,002 9.56 0.1058
2022-02-14 2021-12-31 13F AMGEN COM 031162100 28,408 -1,585 -5.28 6,391 0.20 0.0879
2021-11-15 2021-09-30 13F AMGEN COM 031162100 29,993 -107 -0.36 6,378 -13.07 0.0945
2021-08-16 2021-06-30 13F AMGEN COM 031162100 30,100 105 0.35 7,337 -1.69 0.1060
2021-05-17 2021-03-31 13F AMGEN COM 031162100 29,995 -614 -2.01 7,463 6.04 0.1148
2021-02-16 2020-12-31 13F AMGEN COM 031162100 30,609 -1,072 -3.38 7,038 -12.59 0.1175
2020-11-16 2020-09-30 13F AMGEN COM 031162100 31,681 -812 -2.50 8,052 5.06 0.1540
2020-08-12 2020-06-30 13F AMGEN COM 031162100 32,493 -2,478 -7.09 7,664 8.10 0.1598
2020-05-15 2020-03-31 13F AMGEN COM 031162100 34,971 -4,638 -11.71 7,090 -25.75 0.1762
2020-01-14 2019-12-31 13F Amgen COM 031162100 39,609 -41,421 -51.12 9,549 -39.10 0.1404
2019-10-31 2019-09-30 13F Amgen COM 031162100 81,030 16,617 25.80 15,680 32.10 0.2128
2019-07-31 2019-06-30 13F Amgen COM 031162100 64,413 -2,156 -3.24 11,870 -6.14 0.1538
2019-04-30 2019-03-31 13F Amgen COM 031162100 66,569 11 0.02 12,647 -2.39 0.1688
2019-02-08 2018-12-31 13F Amgen COM 031162100 66,558 2,388 3.72 12,957 -2.59 0.1942
2018-11-13 2018-09-30 13F Amgen COM 031162100 64,170 -29,652 -31.60 13,302 -23.19 0.1676
2018-08-13 2018-06-30 13F Amgen COM 031162100 93,822 -655 -0.69 17,319 7.53 0.2197
2018-05-14 2018-03-31 13F Amgen COM 031162100 94,477 15,465 19.57 16,106 17.22 0.2052
2018-02-13 2017-12-31 13F Amgen COM 031162100 79,012 510 0.65 13,740 -6.13 0.1560
2017-10-30 2017-09-30 13F Amgen COM 031162100 78,502 -9,791 -11.09 14,637 -3.75 0.1683
2017-08-04 2017-06-30 13F Amgen COM 031162100 88,293 686 0.78 15,207 5.80 0.1824
2017-04-28 2017-03-31 13F Amgen COM 031162100 87,607 1,272 1.47 14,374 13.87 0.1754
2017-01-30 2016-12-31 13F Amgen COM 031162100 86,335 7,014 8.84 12,623 -4.60 0.1614
2016-10-31 2016-09-30 13F Amgen COM 031162100 79,321 300 0.38 13,232 10.06 0.1589
2016-08-15 2016-06-30 13F/A-1 Amgen COM 031162100 79,021 -15 -0.02 12,023 1.46 0.1433
2016-07-29 2016-06-30 13F Amgen COM 031162100 79,021 12,023
2016-04-29 2016-03-31 13F Amgen COM 031162100 79,036 875 1.12 11,850 -6.60 0.1570
2016-01-29 2015-12-31 13F Amgen COM 031162100 78,161 1,985 2.61 12,688 20.41 0.1720
2015-10-30 2015-09-30 13F Amgen COM 031162100 76,176 -425 -0.55 10,537 -10.40 0.1410
2015-07-31 2015-06-30 13F Amgen COM 031162100 76,601 690 0.91 11,760 -3.08 0.1385
2015-04-30 2015-03-31 13F Amgen COM 031162100 75,911 75,911 0.00 12,134 0.1426
2015-01-30 2014-12-31 13F Amgen COM 031162100 0 -74,769 -100.00 0 -100.00
2014-10-30 2014-09-30 13F Amgen COM 031162100 74,769 10,605 16.53 10,502 38.28 0.1166
2014-09-18 2014-06-30 13F/A-1 Amgen COM 031162100 64,164 25,293 65.07 7,595 58.43 0.0739
2014-07-30 2014-06-30 13F Amgen COM 031162100 64,164 7,595
2014-04-30 2014-03-31 13F Amgen COM 031162100 38,871 -3,329 -7.89 4,794 -0.42 0.0631
2014-01-30 2013-12-31 13F Amgen COM 031162100 42,200 8,404 24.87 4,814 27.25 0.0647
2013-10-30 2013-09-30 13F Amgen COM 031162100 33,796 -1,261 -3.60 3,783 9.37 0.0472
2013-07-30 2013-06-30 13F Amgen COM 031162100 35,057 35,057 3,459 0.0468
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.